PR

Pretzel Therapeutics

<UNKNOWN> · 5 known investors

pretzeltx.com ↗

Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression. The company leverages expertise in mitochondrial biology and drug discovery to create treatments for diseases associated with mitochondrial dysregulation.

Founders & leadership

MM

Michal MinczukCo-Founder

GM

Gabriel MartinezChief Scientific Officer & Co-Founder

CG

Claes GustafssonCo-Founder

MF

Maria FalkenbergCo-Founder

NL

Nils-Göran LarssonCo-Founder

JP

Jay ParrishChief Executive Officer & Chairman of the Board

Investors · 5

AR

ARCH Venture Partners✓ verifiedChicago · $50K – $250M

CA

Cambridge Innovation Capital✓ verifiedCambridge · $127K – $12.7M

EI

EIR Ventures✓ verifiedStockholm

GV

GV (Google Ventures)Mountain View · $250K – $50M

HE

HealthCapStockholm